Survivor: Smugglers locked hundreds in hold of capsized boat
European leaders urge action after what could be the Mediterranean’s worst migrant tragedy.
Blog
Video: Islamic State kills Ethiopian Christians in Libya
The attack widens the circle of nations affected by the group’s atrocities.
Remembering the Oklahoma City bombing 20 years later
Remembering the Oklahoma City bombing 20 years later
Cuomo to be first U.S. governor to visit Cuba as ties reopen
New York Gov. Andrew Cuomo is heading to Havana, the first American governor to visit Cuba since the recent thaw in relations with the communist nation. Whether his trade mission generates anything more …
Substandard drugs, not fakes, undermine fight against malaria
By Magdalena Mis LONDON (Thomson Reuters Foundation) – Poor quality drugs, not fake medicines, are the real threat in fight against malaria, causing deaths and increasing the risk of drug resistance, researchers said on Monday. While previous reports have suggested that up to a third of malaria drugs could be fake, researchers at the London School of Hygiene and Tropical Medicine who analyzed anti-malaria drugs in Cambodia and Tanzania, found
Teva to pay $512 million to settle claims of delayed generic Provigil
Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers. The settlement is the largest ever to be paid to drug buyers that bought directly from manufacturers over allegations of delaying generic drugs, according to a motion to approve the
Opiate overdoses fall after debut of abuse-resistant OxyContin
By Lisa Rapaport (Reuters Health) – Opiate prescriptions and overdoses in the U.S. have declined since the debut of an abuse-resistant version of the painkiller OxyContin and the market withdrawal of the narcotic Darvon, a study finds. Researchers reviewed insurance claims records with data on prescriptions and hospitalizations for more than 30 million adults covered by UnitedHealthCare from 2003 to 2012. In the two years after OxyContin was reformulated and
3 Secrets to Health Maintenance Success
by guest blogger Pam Peeke, MD, MPH, FACP, best-selling author and expert on health, fitness, and nutritionLet’s say you’re at a point in your wellness journey where you are gradually and proudly hitting critical milestones: You can briskly walk two miles without speed-dialing 911; you can zip up pants and jackets all the way (it’s no longer…
Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake
By Abhishek Vishnoi MUMBAI (Reuters) – Japan’s Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd , setting it on course to retreat from India after a rollercoaster seven years. Daiichi Sankyo bought India’s Ranbaxy Laboratories in 2008, betting on growing global demand for generic drugs, but found itself saddled with a company battling complaints and sanctions from the U.S.
Your Body On The Boston Marathon
From start to finish, here’s how hitting the pavement affects you mentally and physically.